Advanced search
Publication Cover
Journal of Community Hospital Internal Medicine Perspectives Volume 11, 2021 - Issue 6
Journal homepage
4,047
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Role of steroids in critically-ill sepsis patients: a review article and literature to review

Mohsin Mirzaa Internal Medicine Department, Creighton University School of Medicine, Omaha, NE, USA
,
Maryam Zafarb Internal Medicine, Dow University of Health Sciences, DUHS, Karachi, Pakistan
,
Mariam Siddiquib Internal Medicine, Dow University of Health Sciences, DUHS, Karachi, Pakistan
,
Anum Abbasc Internal Medicine Department, University of Nebraska Medical Center, Omaha, NE, USA
,
Joseph Nahasa Internal Medicine Department, Creighton University School of Medicine, Omaha, NE, USA
,
Muazzam Mirzaa Internal Medicine Department, Creighton University School of Medicine, Omaha, NE, USA
&
Abubakar Tauseefa Internal Medicine Department, Creighton University School of Medicine, Omaha, NE, USACorrespondence[email protected]
 show all
Pages 825-829 | Received 22 May 2021, Accepted 30 Jul 2021, Published online: 15 Nov 2021

References

  • Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
  • Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.
  • Annane D, Sharshar T. Cognitive decline after sepsis. Lancet Respir Med. 2015;3(1):61–69.
  • Angus DC, Van Der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–851.
  • Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378:797–808.
  • Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.
  • Pourmand A, Whiteside T, Yamane D, et al. The controversial role of corticosteroids in septic shock. Am J Emerg Med. 2019;37:1353–1361.
  • Annane D, Sébille V, Bellissant E. Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome*. Crit Care Med. 2006;34(1):22–30.
  • Arabi YM, Aljumah A, Dabbagh O, et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. Can Med Assoc J. 2010;182(18):1971–1977.
  • Casserly B, Gerlach H, Phillips GS, et al. Low-dose steroids in adult septic shock: results of the surviving sepsis campaign. Intensive Care Med. 2012;38(12):1946–1954.
  • Nazer L, AlNajjar T, Al-Shaer M, et al. Evaluating the effectiveness and safety of hydrocortisone therapy in cancer patients with septic shock. J Oncol Pharm Pract. 2014;21(4):274–279.
  • Tongyoo S, Permpikul C, Mongkolpun W, et al. Hydrocortisone treatment in early sepsis- associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20:1.
  • Gibbison B, López-López JA, Higgins JPT, et al. Corticosteroids in septic shock: a systematic review and network meta-analysis. Crit Care. 2017;21:1.
  • Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809–818.
  • Goodwin JE, Feng Y, Velazquez H, et al. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc Nat Acad Sci. 2012;110(1):306–311.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.